Terms: = Lung cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Prognosis
113 results:
1. Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
Zhang Q; Li Y; Zhang Y; Deng Z; Ding Y
World J Surg Oncol; 2024 Feb; 22(1):50. PubMed ID: 38336701
[TBL] [Abstract] [Full Text] [Related]
2. Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC.
Zhang H; Zhang D; Liu J; Shi Y; Liu X; Chen M; Zhong W; Zhao J; Xu Y; Wang M
Thorac Cancer; 2023 Nov; 14(32):3191-3201. PubMed ID: 37704455
[TBL] [Abstract] [Full Text] [Related]
3. Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature.
Ishimoto H; Sakamoto N; Kido T; Ozasa M; Tsutsui S; Mori M; Setoguchi D; Takemoto S; Obase Y; Ishimatsu Y; Tomonaga C; Matsumoto K; Morisaki S; Miura K; Mukae H
BMC Pulm Med; 2023 Aug; 23(1):289. PubMed ID: 37553592
[TBL] [Abstract] [Full Text] [Related]
4. Mutations and expressions of breast cancer 1/2 in lung cancer.
Yan B; Xie B; Huang M; Guo J; Sun J; Chen J; Tao Y; Xiao D
Thorac Cancer; 2023 Jun; 14(18):1753-1763. PubMed ID: 37160413
[TBL] [Abstract] [Full Text] [Related]
5. Multimolecular characteristics and role of brca1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis.
Wang R; Zhang J; Cui X; Wang S; Chen T; Niu Y; Du X; Kong J; Wang L; Jiang Y
World J Surg Oncol; 2023 Mar; 21(1):91. PubMed ID: 36907870
[TBL] [Abstract] [Full Text] [Related]
6. Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
Fan J; Yao J; Si H; Xie H; Ge T; Ye W; Chen J; Yin Z; Zhuang F; Xu L; Su H; Zhao S; Xie X; Zhao D; Wu C; Zhu Y; Ren Y; Xu N; Chen C;
Lung Cancer; 2023 Apr; 178():123-130. PubMed ID: 36822017
[TBL] [Abstract] [Full Text] [Related]
7. iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.
Huang Z; Zhang Y
Thorac Cancer; 2023 Mar; 14(8):779-782. PubMed ID: 36747371
[TBL] [Abstract] [Full Text] [Related]
8. The cytologic diagnosis of mesothelioma: are we there yet?
Michael CW
J Am Soc Cytopathol; 2023; 12(2):89-104. PubMed ID: 36702736
[TBL] [Abstract] [Full Text] [Related]
9. Alpha-actnin-4 (ACTN4) selectively affects the DNA double-strand breaks repair in non-small lung carcinoma cells.
Kriger D; Novitskaya K; Vasileva G; Lomert E; Aksenov ND; Barlev NA; Tentler D
Biol Direct; 2022 Dec; 17(1):40. PubMed ID: 36476259
[TBL] [Abstract] [Full Text] [Related]
10. Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia.
Widiasari NPA; Rai IBN; Dwi Kusumawardani IAJ; Sajinadiyasa IGK; Candrawati NW; Arisanti NLPE
Rom J Intern Med; 2023 Mar; 61(1):63-71. PubMed ID: 36453446
[No Abstract] [Full Text] [Related]
11. MicroRNA-3692-3p is overexpressed in lung tumors but may not serve as a prognostic biomarker in lung cancer patients.
Kumar S; Gaur V; Mir IA; Saikia J; Kumar S
Mol Biol Rep; 2023 Feb; 50(2):1147-1156. PubMed ID: 36414877
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic and Prognostic Nomograms for lung Metastasis in Triple-Negative Breast cancer.
Wang J; Zhao H; Ye L; Li J; Zhang H; Zhang C; Rao Q; Cai Y; Xu Y; Deng Y
Comput Math Methods Med; 2022; 2022():1750834. PubMed ID: 35991145
[TBL] [Abstract] [Full Text] [Related]
13. Pan-cancer analysis of the prognostic and immunological role of brca1-associated protein 1 gene (BAP1): Friend or foe?
Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
[TBL] [Abstract] [Full Text] [Related]
14. A predictive model based on liquid biopsy for non-small cell lung cancer to assess patient's prognosis: Development and application.
Gu T; Ren J; Hu Z; Wei Y; Huang J
Tissue Cell; 2022 Aug; 77():101854. PubMed ID: 35752028
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-449a Inhibits Triple Negative Breast cancer by Disturbing DNA Repair and Chromatid Separation.
Vajen B; Bhowmick R; Greiwe L; Schäffer V; Eilers M; Reinkens T; Stalke A; Schmidt G; Fiedler J; Thum T; DeLuca DS; Hickson ID; Schlegelberger B; Illig T; Skawran B
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563522
[TBL] [Abstract] [Full Text] [Related]
16. Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast cancer Treated with Olaparib Monotherapy.
Wang X; Hu N; Cui L; Si Y; Yue J; Zheng F; Kang Y; Yuan P
Curr Cancer Drug Targets; 2022; 22(6):530-536. PubMed ID: 35156571
[TBL] [Abstract] [Full Text] [Related]
17. Role of caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer.
Leiser D; Samanta S; Eley J; Strauss J; Creed M; Kingsbury T; Staats PN; Bhandary B; Chen M; Dukic T; Roy S; Mahmood J; Vujaskovic Z; Shukla HD
PLoS One; 2021; 16(11):e0258951. PubMed ID: 34762666
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract] [Full Text] [Related]
19. Comorbidities and mortality risk among extensive-stage small-cell lung cancer patients in mainland China: impacts of hypertension, type 2 diabetes mellitus, and chronic hepatitis B virus infection.
Xiu W; Huang Y; Li Y; Yu M; Gong Y
Anticancer Drugs; 2022 Jan; 33(1):80-90. PubMed ID: 34183497
[TBL] [Abstract] [Full Text] [Related]
20. Risk factors for postoperative pneumonia and prognosis in lung cancer patients after surgery: A retrospective study.
Yao L; Luo J; Liu L; Wu Q; Zhou R; Li L; Zhang C
Medicine (Baltimore); 2021 Apr; 100(13):e25295. PubMed ID: 33787617
[TBL] [Abstract] [Full Text] [Related]
[Next]
